of poor fetal growth leading to reduced size at birth followed by early postnatal catch-up. The mismatch between a poor intrauterine environment and more favorable postnatal conditions could result in abnormal body composition, which in turn will promote insulin resistance [6] .
Although plasma insulin regulates blood glucose level primarily, insulin-like growth factor-1 (IGF-1) also has a complementary roll through its insulin-like activity on target cells. Circulating concentrations of IGF-1 are regulated by interactions with insulin-like growth factor binding proteins (IGFBPs) as carriers of IGFs [7] , and IGFBP-1 and IGFBP-2 have emerged as potential players maintaining blood glucose levels and insulin [8] . Much attention has focused on IGFBP-1, and most studies have reported that low IGFBP-1 levels are associated with insulin resistance [9] . Although its physiological roles are less well defined than those of IGFBP-1, IGFBP-2 is the second most abundant after a 10 minute rest in the sitting position using a calibrated sphygmomanometer with an appropriated cuff size, and the mean of two measurements was used for analysis. Body composition was evaluated by an eight-polar bioelectrical impedance meter (InBody 3.0, Biospace Inc., Seoul, Korea). Absolute whole body fat (kg), skeletal muscle mass (kg) and percentage of body fat (%) were assessed using the manufacturer's software. A sexual maturity rating (SMR) according to the Marshall and Tanner staging system was assessed by pediatric endocrinologists. The subjects were grouped as a prepubertal group (subjects with SMR I) and a pubertal group (subjects with SMR ≥ II). Each group were subgrouped as the subgroup with height catch-up growth (subjects with Ht-SDS ≥ 0) and the subgroup without height catch-up growth (subjects with Ht-SDS < 0), or the subgroup with weight catch-up growth (subjects with Wt-SDS ≥ 0) and the subgroup without weight catch-up growth (subjects with Wt-SDS < 0).
To compare IGFBP-2 levels of SGA subjects to those of appropriate for gestational age (AGA) children, we also analyzed anthropometric, hormonal and biochemical data from AGA children as controls. The prepubertal and the pubertal control groups were consisted of each 10 healthy AGA children with normal BMI.
Hormone assays and biochemical parameters
Serum IGFBP-2, IGF-1, leptin, adiponectin, glucose, insulin, triglyceride, total cholesterol, low-density lipoprotein (LDL) cholesterol and high-density lipoprotein (HDL) cholesterol concentrations were measured in all subjects. Blood samples were obtained at the morning after fasting.
IGFBP-2 was measured with a sandwich enzymelinked immunosorbent assay (Diagnostic Systems Laboratories, Webster, TX, USA) in which two monoclonal antibodies are directed against separate antigenic determinants on the IGFBP-2 molecule. Serum IGF-1 concentration was measured by immunoradiometric assay (Diagnostic Systems Laboratories, Inc., Webster, TX, USA), and serum leptin and adiponectin concentrations were measured by radio immunoassay (Millipore Research Inc., St. Charles, MO, USA).
Serum levels of glucose, total cholesterol, triglycerides, and HDL cholesterol were measured using a Hitachi-747 automatic analyzer (Tokyo, Japan). LDL cholesterol was calculated using the Friedewald fomula. Serum insulin concentration was estimated using immunoradiometric assay kits (Biosource, circulating IGFBP, and emerging data emphasize an important role for IGFBP-2 in protecting against both obesity and its associated complications including insulin resistance [9, 10] . IGFBP-2 was suggested as a biomarker for identifying insulin resistant adults at high cardiovascular risk [11] . However, there are limited data showing comparable associations between IGFBP-2 levels and insulin sensitivity or cardiovascular risk factors in children born SGA, who are at high risk for long-term metabolic consequences.
In this study, we quantified serum IGFBP-2 concentrations in Korean SGA children and compared IGFBP-2 levels between subgroups with or without catch-up growth. Also, we correlated IGFBP-2 levels with various metabolic risk factors and known insulin sensitivity indices to identify the potential of IGFBP-2 as a biomarker for early detection of insulin resistance in children born SGA.
methods

Subjects and anthropometric measurements
The study population consisted of 103 (46 males and 57 females) Korean children born SGA, ranging in age from 4.2 -16.9 years. We only included the subjects with birth weight below 10th percentile according to age-and gender-matched Korean control values [12] , and all subjects had a gestational age between 37 and 42 weeks. Information about birth weight and gestational age at birth were collected from the birth certificate. None had been treated with recombinant human growth hormone and had preexisting endocrine disorders affecting measures of insulin sensitivity or IGFBP-2 levels, including type 2 diabetes, premature adrenarche, or syndromic obesity. The subjects had been regularly followed-up at the Hallym University Hospital in Korea. The study protocols were reviewed and approved by the Institutional Review Board, and written informed consent was obtained from all subjects or from their parents.
Current height (ht, cm) and weight (wt, kg) were measured using standard methods. Body mass index (BMI) was calculated as wt (kg)/square of the ht (m 2 ). Because the distribution of ht, wt, and BMI, are not even among various age groups of children, we expressed ht, wt, and BMI, as standard deviation score (SDS) according to age-and gender-matched Korean control values [12] . Systolic and diastolic blood pressure (BP, mmHg) was measured twice on the left arm results
Comparisons of clinical and laboratory findings between the subgroups with or without catch-up growth
The baseline clinical and biochemical characteristics of the prepubertal and pubertal SGA groups are shown in Table 1 . Gestational age, birth weight, gender ratio, Ht-SDS and fasting glucose levels did not differ between the two groups. However, Wt-SDS, BMI-SDS, skeletal muscle mass, body fat mass, percent body fat, systolic and diastolic BP increased with age and pubertal development. Also, measured hormones and metabolic parameters including insulin, triglycerides, total cholesterol, LDL and HDL cholesterol, IGF-1, leptin, adiponectin, and IGFBP-2 were different between the two SGA groups.
In the prepubertal AGA controls, the mean age, systolic and diastolic BPs, levels of IGFBP-2 (12.57 ± 6.17 ng/mL, p = 0.81), fasting glucose, triglycerNivelles, Belgium).
Insulin sensitivity indices were calculated from basal fasting glucose and insulin values using the homeostasis model assessment for insulin resistance (HOMA-IR) [13] and the Quantitative Insulin Sensitivity Check Index (QUICKI) [14] .
Statistical analysis
Statistical analyses were performed using PASW version 18.0 (SPSS Inc., Chicago, IL, USA). Student's t-test and the chi-square test were used as appropriate for comparing measured values between the groups and the subgroups. Associations between IGFBP-2, anthropometric measurements, metabolic parameters, and insulin sensitivity indices were investigated by Pearson's correlation and multiple linear regression analysis in each group. A p-value < 0.05 was considered significant. Data are presented as mean ± SD. < 0.001) and percent body fat (p < 0.001), though skeletal muscle mass did not differ from that of the subgroup without weight catch-up. Systolic BP (p = 0.07) also showed a tendency to increase in the weight catch-up subjects. Fasting glucose, insulin, triglycerides, HDL cholesterol, IGF-1 and adiponectin levels were similar between two subgroups regardless of weight catch-up. But, higher levels of leptin (p < 0.001) and total cholesterol (p = 0.02) were observed, and LDL cholesterol (p = 0.06) and IGFBP-2 (p = 0.06) also showed a tendency to increase in the weight catch-up subjects.
in the pubertal Sga children (table 3) The height catch-up subgroup showed higher values of skeletal muscle mass (p = 0.001), systolic (p = 0.04) and diastolic (p = 0.04) BP than the subgroup without height catch-up. Body fat mass, percent body fat, blood levels of fasting glucose, insulin, triglycerides, cholesterol profiles, leptin, adiponectin, and IGFBP-2 did not differ between two groups regardless of height catch-up.
Comparing between the subgroups with and without weight catch-up, the weight catch-up group showed ides, total cholesterol, LDL and HDL cholesterol were not different to those of the prepubertal SGA group. Despite BMI-SDS (0.13 ± 0.78, p = 0.005) was higher in the prepubertal AGA controls, levels of insulin (3.90 ± 2.56, p = 0.02) and HOMA-IR (0.96 ± 0.67, p = 0.03) were significantly lower, and levels of QUICKI (0.41 ± 0.05, p = 0.002) was significantly higher than those of the prepubertal SGA group. In the pubertal AGA controls, we could not observe any statistical difference to values of the pubertal SGA group, including levels of IGFBP-2 (8.96 ± 3.26 ng/mL, p = 0.48).
Each SGA group was subdivided into the subgroups with or without catch-up growth. Catch-up growth in height as well as weight was separately considered to compare clinical and laboratory characteristics between the subgroups.
in the prepubertal Sga children (table 2)
Between the subgroups with and without height catch-up, there was no difference in body composition, metabolic and cardiovascular risk factors.
However, the subgroup with weight catch-up showed higher values of BMI-SDS (p < 0.001), body fat mass (p In addition, we evaluated the association of serum IGFBP-2 levels with several metabolic and cardiovascular risk factors associated with insulin resistance in prepubertal and pubertal SGA children with multiple regression analyses. These analyses revealed that IGFBP-2 was associated with insulin and total choleshigher values in birth weight (p = 0.001), BMI-SDS (p < 0.001), skeletal muscle mass (p = 0.003), body fat mass (p < 0.001) and percent body fat (p < 0.001). Systolic BP (p = 0.07) also showed a tendency to increase in the weight catch-up subgroup. Fasting glucose, insulin, triglycerides, HDL cholesterol, IGF-1, leptin and adiponectin levels were similar between two subgroups regardless of weight catch-up. But, higher levels of total (p = 0.02) and LDL cholesterol (p = 0.02), and lower level of IGFBP-2 (p = 0.03) were observed in the weight catch-up subjects. Table 4 shows correlations between IGFBP-2 and auxological and laboratory parameters in prepubertal and pubertal SGA children.
Associations between IGFBP-2 levels and metabolic and cardiovascular risk factors
In the prepubertal group, significant inverse correlations were observed with BMI-SDS (r = -0.36, p = 0.03), body fat mass (r = -0.51, p = 0.001), percent body fat (r = -0.33, p = 0.03), insulin (r = -0.36, inantly expressed in liver, adipocytes, the reproductive system and the central nervous system in adults [15] . Plasma levels of IGFBP-2 shows fewer fluctuations over 48 hours in healthy individuals than those of IGFBP-1, with no notable changes postprandially or after a glucose challenge [16] . IGFBP-2 concentrations increase after a prolonged period of fasting, indicating that IGFBP-2 concentrations might reflect longterm alterations in hepatic exposure to insulin, whereas IGFBP-1 reflects short-term variations in insulin levels [16] . The physiological role of IGFBP-2 and its metabolic regulation in humans remains poorly understood.
terol levels in pubertal SGA children, even after adjustment for age, gender, SMR, birth weight, percent body fat, and BMI-SDS (Table 5 ). However, in prepubertal SGA children, we could not find meaningful relation between IGFBP-2 levels and metabolic and cardiovascular risk factors in multiple regression analysis (data not shown).
Discussion
IGFBP-2 is an approximately 36 kDa protein that is expressed during fetal development and is predom- the weight catch-up subgroups of both prepubertal and pubertal children showed higher BMI-SDS, body fat mass and percent body fat. Lower IGFBP-2 levels were also observed in weight catch-up subgroups of pubertal SGA children. In the prepubertal SGA children, we also could find a tendency that IGFBP-2 levels were reduced in the subgroup with weight catch-up, though the difference of IGFBP-2 levels between the subgroups with or without weight catch-up did not reach statistical significance (p = 0.06).
Puberty is also related to a 50% decrease in insulin sensitivity. The decrease in insulin sensitivity is compensated by a doubling in insulin secretion, and is independent of changes in percentage of body fat [23] . Increasing total body lipolysis and decreasing glucose oxidation are observed during puberty. However, pubertal insulin resistance is physiological and is resolved by the end of puberty [23] . Therefore, it is complicated and difficult to assess insulin resistance and cardiovascular risks in children and adolescents. Also in the present study, serum IGFBP-2 concentration was significantly lower in the pubertal than that in the prepubertal SGA children. And, pubertal SGA children showed significant correlation between IGFBP-2 levels and several metabolic parameters including insulin, HOMA-IR, QUICKI, total and LDL cholesterols, and leptin levels. IGFBP-2 levels correlated with several metabolic markers including insulin, HOMA-IR, IGF-1 and leptin levels, even in the prepubertal SGA children.
Two major adipocytokines, leptin and adiponectin, are thought to play important roles in the regulation of cardiovascular and metabolic homeostasis. A strong positive correlation between leptin and insulin concentrations was identified, and insulin sensitive subjects have lower leptin concentrations than those with insulin resistance, independent of body fat mass [24, 25] . Then, leptin is thought to be a marker of body fat and hyperinsulinemia. Our results also showed adiponectin levels were increased with age and pubertal development and were higher in prepubertal SGA children with weight catch-up than those without catch-up. A strong correlation was observed between leptin and IGFBP-2 levels in both prepubertal and pubertal groups. Therefore, with leptin, serum IGFBP-2 could serve as an early marker for identification of insulin resistance and metabolic syndrome in SGA children with weight catch-up.
Adiponetin has insulin-sensitizing and anti-arthrogenic properties. Reduced concentrations of adiponectin precede the onset of type 2 diabetes and the develStudies in mice with IGFBP2 gene alterations suggest that IGFBP-2 prevents the development of insulin resistance associated with obesity and advancing age [10, 17] . Although evidence for this association is less strong than for IGFBP-1, previous studies have also indicated that IGFBP-2 is involved in metabolic homeostasis. IGFBP-2 concentrations are inversely correlated with BMI, plasma insulin levels, and markers of insulin resistance [11, 18, 19] .
Reduced fetal growth is independently associated with increased risk of health problems in later life, particularly type 2 diabetes and cardiovascular diseases. Insulin resistance appears to be the key component underlying these metabolic consequences. Previous studies have indicated that most of these complications are closely related with to low birth weight and rapid postnatal catch-up in weight [20] . Insulin sensitivity is decreased in SGA subjects compared to subjects born AGA, in spite of a similar BMI in their adulthood [21] . In this study, we also observed that the prepubertal SGA group showed higher values of fasting insulin and HOMA-IR, and lower values of QUICKI in comparison to the prepubertal AGA controls, even though BMI-SDS was higher in the control group. The risk of developing metabolic complications is also influenced by changes in adiposity beyond the catch-up growth period during later childhood or adulthood [22] . Although IGFBP-2 levels were not significantly different between SGA subjects and AGA controls in both prepubertal and pubertal groups in this study, serum IGFBP-2 concentration was closely related to current BMI in both pubertal and prepubertal SGA groups. Also, fasting insulin levels and insulin sensitivity indices including HOMA-IR and QUICKI were significantly correlated with IGFBP-2 levels. These findings suggest that IGFBP-2 can serve as a marker for insulin resistance in children and adolescent.
Body fat mass and fat distribution are important determinants of insulin sensitivity, and abnormalities of adipose tissue have been demonstrated, suggesting a critical role for this organ in the development of metabolic complications in SGA subjects [6] . In the present study, body fat mass and percent body fat were inversely correlated with serum IGFBP-2 concentration in both prepubertal and pubertal children, while skeletal muscle mass was not associated with serum IGFBP-2 levels. We could not find influence of height catch-up on insulin levels, insulin sensitivity indices or IGFBP-2 levels, regardless of pubertal stage. However, IGFBP-2 levels correlated inversely with insulin and total cholesterol levels after adjustment of age, gender, SMR, birth weight, percent body fat, and BMI-SDS in the pubertal SGA children. These close relationships support the robustness of IGFBP-2 as a predictive biomarker for cardiovascular diseases in later life of children born SGA.
In conclusion, circulating IGFBP-2 levels in children born SGA were inversely associated with adiposity and insulin sensitivity. With age and pubertal development, more metabolic or cardiovascular risk factors were correlated with IGFBP-2 concentrations. Pubertal children with weight catch-up showed decreased levels of IGFBP-2 than those without catch-up. Considering to fewer diurnal fluctuation of serum IGFBP-2 level than other markers of insulin resistance, screening with serum IGFBP-2 concentration would be useful and convenient to identify insulin resistance in SGA children at risk. opment of artherosclerosis. Although some previous studies suggested that adiponectin levels are reduced in SGA children and are even lower in those with postnatal catch-up growth [26] , there have been limited number of studies on adiponectin levels in SGA children and the results have revealed conflicting levels, either low or normal or even high in the face of hyperinsulinaemia [27, 28] . In this study, pubertal children showed higher levels of adiponectin than prepubertal children, however we could not observe the difference in adiponectin levels between the subgroups with or without catch-up, and there was no relationship between adiponectin and IGFBP-2 levels. Further studies are required to assess whether the differences between SGA children and controls or between SGA children with or without catch-up observed during a long term follow-up duration.
The serum level of total cholesterol is one of established makers of cardiovascular risks [29] . From the multiple regression analysis in the present study, serum references
